Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Pharmacoeconomics
|
January 7, 1998
Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel
G Ginsberg, S Shani, B Lev
The Israel Medical Association Journal : IMAJ
|
July 18, 2000
Patients' perceptions of drug therapy counseling in Israel
S Shani, T Morginstin, A Hoffman
Harefuah
|
January 16, 2002
[Adverse drug reactions definitions and terminology]
H Rabinovitz, M Berkowitch, A Golik, et al.
Harefuah
|
July 7, 2000
[Israel hospital pharmaceutical services: a national survey]
S Livny, A Hammerman, S Shani, et al.
Harefuah
|
May 9, 2001
[Regulation of natural medicines in Israel and abroad]
T Lavy, B Haran, J Shemer, et al.
Health Policy (Amsterdam, Netherlands)
|
January 13, 2001
Setting priorities for the adoption of health technologies on a national level -- the Israeli experience
S Shani, M I Siebzehner, O Luxenburg, et al.
Harefuah
|
March 26, 2003
[Promoting medical technologies in the national list of health services: 1995-2000]
J Shemer, T Morginstin, A Hammerman, et al.
Pediatric Research
|
February 1, 1977
Serum calcitonin and blood mineral interrelationships in normal children aged six to twelve years
R Shainkin-Kerstenbaum, B Funkenstein, A Conforti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1982
Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3
D Feldman, T Chen, C Cone, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change
E Schwartzberg, S Rubinovich, D Hassin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Pharmacoeconomics
|
January 7, 1998
Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel
G Ginsberg, S Shani, B Lev
The Israel Medical Association Journal : IMAJ
|
July 18, 2000
Patients' perceptions of drug therapy counseling in Israel
S Shani, T Morginstin, A Hoffman
Harefuah
|
January 16, 2002
[Adverse drug reactions definitions and terminology]
H Rabinovitz, M Berkowitch, A Golik, et al.
Harefuah
|
July 7, 2000
[Israel hospital pharmaceutical services: a national survey]
S Livny, A Hammerman, S Shani, et al.
Harefuah
|
May 9, 2001
[Regulation of natural medicines in Israel and abroad]
T Lavy, B Haran, J Shemer, et al.
Health Policy (Amsterdam, Netherlands)
|
January 13, 2001
Setting priorities for the adoption of health technologies on a national level -- the Israeli experience
S Shani, M I Siebzehner, O Luxenburg, et al.
Harefuah
|
March 26, 2003
[Promoting medical technologies in the national list of health services: 1995-2000]
J Shemer, T Morginstin, A Hammerman, et al.
Pediatric Research
|
February 1, 1977
Serum calcitonin and blood mineral interrelationships in normal children aged six to twelve years
R Shainkin-Kerstenbaum, B Funkenstein, A Conforti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1982
Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3
D Feldman, T Chen, C Cone, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change
E Schwartzberg, S Rubinovich, D Hassin, et al.
Page
of 3